The U.S. glucose monitoring landscape has shifted
The way Americans track blood sugar has changed more in the last three years than in the previous two decades. Traditional fingerstick meters still dominate pharmacy shelves, but continuous glucose monitors (CGMs) have moved from a niche prescription tool to a mainstream option. The shift accelerated when over-the-counter sensors became available to adults who are not on insulin, opening the market to anyone curious about how their body responds to food, stress, and sleep.
That matters for a practical reason. A standard fingerstick meter gives you a snapshot, often taken at the wrong moment. A CGM reads your glucose every few minutes and shows the curve, not just the number. For someone like Mark, who wants to know whether the burrito at lunch really spikes him, that difference is meaningful.
What most people get wrong when choosing a monitor
The insurance assumption
Many Americans assume their health plan will cover a CGM, and many plans do for people with diabetes who meet certain criteria. But coverage varies widely by state, employer plan, and whether you use insulin. Some plans require prior authorization, others ask for proof that you have failed on oral medications. The person who assumes coverage without checking often ends up with an unexpected bill.
The prescription confusion
FreeStyle Libre 3 and Dexcom G7 require a prescription, even though they are widely available. That means a doctor visit, a pharmacy order, and sometimes a call to your insurer. Stelo and Lingo, the newer over-the-counter options, skip that step entirely. You buy them like you would a vitamin, but the tradeoff is that they are marketed for wellness rather than diabetes management.
The sticker shock of ongoing costs
The meter itself is often the cheapest part. What nobody tells you is that test strips and sensors are where the money goes. A traditional meter can cost less than twenty dollars, but strips run anywhere from forty cents to a dollar each, and most people use two to four per day. On the CGM side, sensors are replaced every ten to fifteen days, which adds up to a recurring expense that fingerstick users never factor in.
Comparing the main options side by side
| Category | Example Model | Price Range | Best For | Strengths | Tradeoffs |
|---|
| Prescription CGM | Dexcom G7 | $170-$490 per 30 days without insurance | People with diabetes needing real-time alerts | 15-day sensor, smartphone alerts, insulin pump compatible | Requires prescription; receiver costs extra |
| Prescription CGM | FreeStyle Libre 3 | $170-$200 per 30 days without insurance | People wanting the smallest sensor | Coin-sized sensor, 15-day wear, no calibration | Prescription required; app requires newer phones |
| OTC wellness CGM | Dexcom Stelo | $89-$99 per month | Adults 18+ not on insulin | No prescription, HSA/FSA eligible, 15-day wear | Not for diabetes management; subscription model |
| OTC wellness CGM | Abbott Lingo | About $50 per 2 weeks | Adults curious about metabolic health | Sold at Walmart, no prescription | Higher per-day cost; wellness focus only |
| Traditional meter | ReliOn Premier, Contour Next | $5-$20 for the meter | Budget-focused daily testing | Cheap upfront, strips sold everywhere | Requires fingersticks; no trend data |
Prices shift by region and retailer. A two-pack of Stelo sensors runs about $99 at retail, while Abbott's Lingo two-week pack sells for just under $50 at Walmart, which became the first major U.S. retailer to stock an OTC CGM. On the prescription side, a 30-day supply of Dexcom G7 sensors averages around $489 without insurance, and the FreeStyle Libre 3 comes in near $172. These figures change, so treat them as planning numbers, not guarantees.
Making the right call for your situation
If you have diabetes and use insulin
Your doctor will almost certainly recommend a prescription CGM, and for good reason. Real-time alerts for dangerously low blood sugar are the strongest safety argument these devices have. The Dexcom G7 and FreeStyle Libre 3 both connect to smartphones, share data with caregivers, and integrate with insulin pumps. If Medicare or your employer plan covers CGMs, the out-of-pocket cost drops dramatically. Check your plan's formulary before buying anything.
If you have type 2 diabetes and do not use insulin
This is where the decision gets interesting. Your insurance may cover a CGM if you meet their criteria, but if it does not, you now have two OTC options that did not exist a few years ago. Stelo costs about $89 per month with a subscription and lasts fifteen days per sensor. That is not cheap, but it beats the $489 monthly bill for an uncovered Dexcom G7. For many people in this group, Stelo or Lingo is the financially sensible middle path.
If you are monitoring for general health
Maybe you have prediabetes, a family history, or just a doctor who said your fasting glucose was creeping up. The OTC sensors are worth a try, but be realistic about what they tell you. They show patterns, like how a bowl of oatmeal at 7 a.m. affects your energy at 10 a.m., which is genuinely useful for building better habits. They are not diagnostic tools. If your goal is to catch a real problem, see a clinician instead.
Where to buy and how to save
Walmart now carries the Abbott Lingo in more than 3,500 stores, which is significant because it normalizes buying a glucose sensor off the shelf. Stelo is available through its own site and Amazon. For prescription CGMs, Amazon Pharmacy and GoodRx both publish discounted cash prices that often beat local pharmacies. Manufacturer savings programs can lower the cost of Dexcom sensors for people who qualify, and patient assistance programs exist for those with financial need.
One practical tip: check whether your health savings account or flexible spending account covers these devices. Most OTC CGMs qualify as eligible expenses, which effectively gives you a discount if you pay with pre-tax dollars.
A few cautions before you commit
No monitor replaces a conversation with your doctor, especially if you take medications that can cause lows. If you lie on a CGM sensor overnight, you can get a compression low, a falsely low reading from pressure on the device, so do not panic-adjust insulin based on one number. And while the OTC devices are cleared for adults 18 and older who are not on insulin, the evidence on whether wearing one improves long-term health in otherwise healthy people is still emerging. Treat the data as insight, not diagnosis.
Action steps
- Check your insurance first. Call your plan or log in to your portal and search for continuous glucose monitor coverage. Ask about prior authorization requirements and what your copay would be.
- Ask your doctor for a prescription if you need one. A 15-minute telehealth visit can get you a prescription for Libre 3 or Dexcom G7 if you have diabetes.
- Compare cash prices online. GoodRx and Amazon Pharmacy publish real-time prices. In many cases, the cash price at one pharmacy beats your copay at another.
- Try the OTC route if you are not on insulin. A two-week Lingo pack or a month of Stelo tells you quickly whether the data changes your behavior enough to justify the recurring cost.
- Start with a full sensor cycle before judging. The first few days are a learning curve. Give yourself two full weeks before deciding if a CGM earns its place in your routine.
Mark from Dallas finally tried a CGM through a month of Stelo. What he learned is that his morning protein shake kept his glucose steady, while the convenience-store muffins he grabbed on break caused spikes he never saw with fingersticks. He still tests with a meter now and then, but he wears a sensor when he wants answers instead of guesses. That is the real value of a blood sugar monitor in 2026, not the gadget itself, but the pattern it finally makes visible.
研究の知恵